Journal of Southern Medical University ›› 2006, Vol. 26 ›› Issue (08): 1206-1208.

Previous Articles     Next Articles

Clinical observation of target-controlled remifentanil infusion combined with propofol and doxapram in painless artificial abortion

TAN Zhi-min, LIU Jian-hua, DONG Tao, LI Jia-xing Department of Anesthesiology, Conghua Central Hospital, Conghua 510900, China   

  1. 从化市中心医院麻醉科; 从化市中心医院麻醉科 广东从化510900; 广东从化510900;
  • Online:2006-08-20 Published:2006-08-20

Abstract: Objective To observe the impacts of doxapram on anesthetic efficacy and respiratory and circulatory functions during anesthesia with remifentanil given by target-controlled infusion (TCI) combined with propofol in painless artificial abortion. Methods A total of 120 ASA Ⅰ women reguiring voluntarily painless artificial abortion were randomized into two equal groups. One group was given remifentanil by TCI at 2 ng/ml and propofol 1mg/kg (group I), and the other given remifentanil by TCI, propofol, and doxapram 0.6 mg/kg (group II). The anesthetic efficacy and respiratory and circulatory suppression during anesthesia were observed. Results Both of the two groups showed satisfactory anesthetic efficacy with comparable the BIS values (P>0.05). No significant difference was noted in the induction time and awaking time between the two groups (P>0.05), but group I had more serious respiratory and circulatory depression than group II (P<0.05). Conclusion Doxapram may attenuate respiratory and circulatory depression during anesthesia with remifentanil given by TCI combined with propofol in painless artificial abortion, and provide comparable anesthetic efficacy. 

CLC Number: